CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

A study of renal function, serum sodium and their impact on survival of patients with end stage liver disease

Author: 
Girinadh Lekkala, R.S., Ravi Kumar Allu, Sravan Kumar Korrapati
Subject Area: 
Health Sciences
Abstract: 

Background: Serum creatinine is considered to reflect renal function; however, it is not a very accurate gauge, especially in detecting early loss of renal function. To estimate the role of serum creatinine, sodium, and estimated glomerular filtration rate (eGFR) as determinants of survival in patients with End stage liver disease (CTP-C). Methods: Patients with decompensated cirrhosis (CTP-C) and serum creatinine ≤ 1.5 mg/dl were included in the study. Patients with Diabetes, Hypertension, Post-transplant candidates were excluded. MELD was calculated by MELD Score. MELD Na was calculated by MELD-Na = MELD +1.59 (135 - Na).eGFR was calculated by the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) formula. The primary event of interest in this study was death within 6 months. Results: Total 64 patients were included in the study. 30(46.8%) were having alcohol, 19 (29.6%) patients had viral etiology as the cause of cirrhosis. Out of 64 patients, 18 patients (28.12%) died during 6 months follow up. Hyponatremia was present in 61.1% of dead patients and 21.7% of survived patients. eGFR was ≥90ml/min/1.73m2 in 12 patients, 16% died. eGFR was 60-89 ml/min/1.73m2in 32 patients,25% died and eGFR was <60 ml/min/1.73m2in 20 patients, 40% died. Univariate Analysis of Baseline Variables showed serum creatinine had no significance in the survival of patients with end stage liver disease (CTP-C). MELD score, eGFR, serum sodium and MELD-Na had significance in the survival. Multivariate Cox Regression Summaries for MELD, Hyponatremia, and MELD plus Serum Sodium in Predicting Death Considering 6-Month Follow-Up Data showed c-Static for MELD is 0.75 where as c-Static for MELD-Na is 0.805 and for a model comprising bilirubin, INR, eGFR and sodium is 0.816. Conclusions: When compared to serum creatinine, eGFR is a better tool for estimating survival of patients with ESLD. As eGFR decreases the percentage of mortality increases.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran